HOSPITAL UNIVERSITARIO RUBER
Departamento
German Cancer Research Center
Heidelberg, AlemaniaPublicaciones en colaboración con investigadores/as de German Cancer Research Center (3)
2023
2022
2019
-
IMpassion132 Phase III trial: Atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer
Future Oncology, Vol. 15, Núm. 17, pp. 1951-1961